Jeff Yass’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $342K | Buy |
10,904
+4,206
| +63% | +$177K | ﹤0.01% | 10760 |
|
|
2026
Q1 | $370K | Buy |
6,698
+987
| +17% | +$47K | ﹤0.01% | 10400 |
|
|
2025
Q4 | $213K | Sell |
5,711
-41,241
| -88% | -$1.68M | ﹤0.01% | 10739 |
|
|
2025
Q3 | $1.9M | Buy |
46,952
+9,727
| +26% | +$321K | ﹤0.01% | 5903 |
|
|
2025
Q2 | $951K | Buy |
37,225
+3,722
| +11% | +$81.2K | ﹤0.01% | 7560 |
|
|
2025
Q1 | $716K | Buy |
33,503
+17,513
| +110% | +$391K | ﹤0.01% | 8088 |
|
|
2024
Q4 | $336K | Buy |
15,990
+4,157
| +35% | +$96.2K | ﹤0.01% | 9580 |
|
|
2024
Q3 | $266K | Buy |
+11,833
| New | +$228K | ﹤0.01% | 9845 |
|
|
2024
Q2 | – | Sell |
-15,211
| Closed | -$197K | – | 12918 |
|
|
2024
Q1 | $197K | Buy |
15,211
+1,491
| +11% | +$17.9K | ﹤0.01% | 10607 |
|
|
2023
Q4 | $159K | Buy |
+13,720
| New | +$155K | ﹤0.01% | 10917 |
|
|
2023
Q2 | – | Sell |
-22,533
| Closed | -$345K | – | 12843 |
|
|
2023
Q1 | $345K | Buy |
+22,533
| New | +$344K | ﹤0.01% | 9419 |
|
|
2021
Q3 | – | Sell |
-10,836
| Closed | -$313K | – | 13327 |
|
|
2021
Q2 | $313K | Buy |
+10,836
| New | +$293K | ﹤0.01% | 10693 |
|
|
2019
Q4 | – | Sell |
-12,147
| Closed | -$259K | – | 10384 |
|
|
2019
Q3 | $259K | Buy |
12,147
+1,322
| +12% | +$36.2K | ﹤0.01% | 8621 |
|
|
2019
Q2 | $344K | Buy |
+10,825
| New | +$339K | ﹤0.01% | 8054 |
|
|
2018
Q3 | – | Sell |
-5,863
| Closed | -$277K | – | 9963 |
|
|
2018
Q2 | $270K | Buy |
+5,863
| New | +$260K | ﹤0.01% | 8050 |
|
|
2017
Q3 | – | Sell |
-5,923
| Closed | -$219K | – | 9405 |
|
|
2017
Q2 | $219K | Buy |
+5,923
| New | +$193K | ﹤0.01% | 8130 |
|
|
2017
Q1 | – | Sell |
-26,922
| Closed | -$789K | – | 9678 |
|
|
2016
Q4 | $789K | Buy |
+26,922
| New | +$735K | ﹤0.01% | 6018 |
|
|
2016
Q2 | – | Sell |
-16,500
| Closed | -$446K | – | 9124 |
|
|
2016
Q1 | $446K | Buy |
16,500
+6,255
| +61% | +$179K | ﹤0.01% | 6607 |
|
|
2015
Q4 | $309K | Sell |
10,245
-24,735
| -71% | -$794K | ﹤0.01% | 7638 |
|
|
2015
Q3 | $1.11M | Buy |
34,980
+24,326
| +228% | +$888K | ﹤0.01% | 5526 |
|
|
2015
Q2 | $415K | Sell |
10,654
-15,523
| -59% | -$535K | ﹤0.01% | 7979 |
|
|
2015
Q1 | $927K | Buy |
+26,177
| New | +$843K | ﹤0.01% | 5910 |
|
|
2014
Q3 | – | Sell |
-45,790
| Closed | -$1M | – | 9797 |
|
|
2014
Q2 | $1M | Buy |
+45,790
| New | +$870K | ﹤0.01% | 6042 |
|
Other funds holding PAHC
Jeff Yass's PAHC Position: Q2 2026 in Review
Jeff Yass increased its Phibro Animal Health (PAHC) stake by 63% in Q2 2026, buying an estimated $177K and bringing the position to 10,904 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #10760.
Jeff Yass first reported a position in PAHC in Q2 2014 and has held it in 23 quarters since. The position peaked at $1.9M in Q3 2025. 207 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Jeff Yass held 10,904 shares of Phibro Animal Health worth $342K as of Q2 2026.
- Jeff Yass bought 4,206 Phibro Animal Health shares in Q2 2026, an estimated $177K.
- Phibro Animal Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10760 holding.
- Jeff Yass first reported a position in Phibro Animal Health in Q2 2014 and has held it in 23 quarters since.
- Jeff Yass's Phibro Animal Health position peaked at $1.9M in Q3 2025.
- 207 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.